Figure 4.

Downregulation of LINC00704 inhibits cell proliferation and cell‐cycle progression in thyroid cancer. A, The fold‐change of LINC00704 expression levels between thyroid cancer tissues and normal tissues in TCGA dataset. B, The Kaplan‐Meier curves for thyroid cancer patients’ OS in high‐LINC00704 and low‐LINC00704 groups in the TCGA dataset. C, The relative expression of LINC00704 in negative control or LINC00704 siRNAs transfected BHT101 and BCPAP cells was detected by qRT‐PCR. D, Growth curves of BHT101 and BCPAP cells after transfection with LINC00704 siRNAs or negative control were determined by CCK8 assays. Values represent the mean ± SD from three independent experiments. E, The colony formation ability of BHT101 and BCPAP cells after transfection with LINC00704 siRNAs or negative control were determined. F, The cell‐cycle progression of BHT101 and BCPAP cells after transfection with LINC00704 siRNAs or negative control was determined using Flow cytometry assays. **P < .01; *P < .05